Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis. [electronic resource]
Producer: 20170906Description: 421-430.e6 p. digitalISSN:- 1542-7714
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Clinical Trials, Phase III as Topic
- Drug Therapy, Combination -- methods
- Female
- Hepatitis C, Chronic -- complications
- Heterocyclic Compounds, 4 or More Rings -- therapeutic use
- Humans
- Liver Cirrhosis
- Male
- Middle Aged
- Patient Reported Outcome Measures
- Ribavirin -- therapeutic use
- Sofosbuvir -- therapeutic use
- Surveys and Questionnaires
- Sustained Virologic Response
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.